 |
|
M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers
October 27, 2009Best practices in cancer screening translated into risk-based guidelines for the public
HOUSTON - Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers.
The new recommendations represent the first wave of an effort by M. D. Anderson to improve the effectiveness of efforts to prevent and detect cancer at its earliest, most treatable stage by reconstructing and expanding its screening, risk reduction and diagnostic guidelines across eight disease sites.
Available on M. D. Anderson's Web site, the recommendations translate best practices in cancer prevention employed at M. D. Anderson into accessible guidelines the public can follow, with risk categories identified and information about when to begin and discontinue screening exams.
According to the American Cancer Society, more than 40 percent of Americans will develop cancer during their lifetime, and cancers that can be prevented or detected earlier by screening account for at least half of all new cancer cases.
"Cancer screening is not one-size-fits-all," said Therese Bevers, M.D., medical director of M. D. Anderson's Cancer Prevention Center. "Our new risk-based recommendations are markedly more personalized and precise, offering detailed guidance than what has previously been made available to the public here or by other cancer organizations."
Until now, cancer screening recommendations were targeted largely to individuals at average risk for developing cancer based on characteristics like age, family history or genetic predisposition. However, average risk was not previously defined and recommendations for individuals at increased or high risk were not outlined. The new screening guidelines define risk and offer recommendations for those at increased and high risk of developing cancer. For example, there are now five different sets of screening recommendations for those at increased risk for breast cancer; four categories of age-based risk recommendations for cervical cancer; and for colorectal cancer, there are three categories defining those at increased risk and three categories defining those at high risk.
The new guidelines build on established cancer screening practices and now more specifically offer the following recommendations:
Breast Cancer
Starting at age 20, women at all risk levels should practice breast self-awareness by being familiar with how their breasts look and feel and immediately reporting any changes to their doctor. Women aged 40 years and older at average risk should get annual mammograms and breast exams.
For women at increased risk, the type and frequency of exams - including clinical breast exams, mammograms and breast MRI - depend on factors putting them at increased risk, including:
* history of radiation treatment to the chest;
* genetic predisposition;
* diagnosis of lobular carcinoma in situ;
* Gail Model score of greater than 1.7 percent;
* or family history.
Cervical Cancer
For women at average risk, it is now recommended that women under age 21 get a liquid-based Pap test within three years of initiating vaginal intercourse. She should continue to have Pap tests annually until she has had three consecutive negative test results. After that, M. D. Anderson recommends screening every two years unless she is at increased risk of cervical cancer based on risk factors, including:
* history of cervical cancer or severe cervical dysplasia;
* persistently testing positive for Human Papilloma Virus (HPV);
* exposure to diethylstilbestrol (DES) before birth;
* Human Immunodeficiency Virus (HIV) infection;
* or an immune system that does not function properly.
Beginning at age 30, adding HPV testing is a preferred option to the Pap test, and if both are negative, a woman may go to every three years unless she is at increased risk based on the risk factors cited above or unless the optional HPV test was not done.
Colorectal Cancer
M. D. Anderson recommends a colonoscopy every 10 years (preferred screening), a virtual colonoscopy every five years, or a yearly Fecal Occult Blood Test (FOBT) for men and women aged 50 years and older who are at average risk. For men and women at increased or high risk, the type and frequency of exams - including colonoscopy and flexible sigmoidoscopy - depend on the following factors:
* personal history of precancerous (adenomatous) polyps;
* personal history of colorectal cancer;
* family history of colorectal cancer or precancerous (adenomatous) polyps;
* genetic diagnosis of Familial Adenomatous Polyposis;
* genetic history of Hereditary Nonpolyposis Colorectal Cancer or a clinical history suggesting such;
* or inflammatory bowel disease (ulcerative colitis or Crohn's disease).
"Because of the research being conducted in laboratories and clinics at M. D. Anderson and around the world, our understanding of how cancer develops and spreads is steadily increasing," said Ernest T. Hawk, M.D., M.P.H., vice president for Cancer Prevention and Population Sciences.
More knowledge about how doctors make decisions about risk levels and screening tests will give patients a deeper understanding of the disease process and enable them to put their own cancer risk in perspective, he added.
"For colorectal cancer screenings, patients need to be proactive about obtaining results from their screening tests. For example, if a colonoscopy reveals polyps, it is critical for the patient to know what kind, how many and what size, since this information factors heavily into what risk category they fall into for colorectal cancer," Bevers said.
The risk categories and related guidelines were developed by multidisciplinary panels of M. D. Anderson disease site experts across several areas, including: medical oncology, surgical oncology, cancer prevention, imaging and others. Risk-based screening guidelines for prostate, liver, skin, endometrial and ovarian cancers are currently in development and a new online risk assessment tool integrating the new screening guidelines will be launched on the M. D. Anderson Web site in early 2010.
University of Texas M. D. Anderson Cancer Center
Available on M. D. Anderson's Web site, the recommendations translate best practices in cancer prevention employed at M. D. Anderson into accessible guidelines the public can follow, with risk categories identified and information about when to begin and discontinue screening exams.
According to the American Cancer Society, more than 40 percent of Americans will develop cancer during their lifetime, and cancers that can be prevented or detected earlier by screening account for at least half of all new cancer cases.
"Cancer screening is not one-size-fits-all," said Therese Bevers, M.D., medical director of M. D. Anderson's Cancer Prevention Center. "Our new risk-based recommendations are markedly more personalized and precise, offering detailed guidance than what has previously been made available to the public here or by other cancer organizations."
Until now, cancer screening recommendations were targeted largely to individuals at average risk for developing cancer based on characteristics like age, family history or genetic predisposition. However, average risk was not previously defined and recommendations for individuals at increased or high risk were not outlined. The new screening guidelines define risk and offer recommendations for those at increased and high risk of developing cancer. For example, there are now five different sets of screening recommendations for those at increased risk for breast cancer; four categories of age-based risk recommendations for cervical cancer; and for colorectal cancer, there are three categories defining those at increased risk and three categories defining those at high risk.
The new guidelines build on established cancer screening practices and now more specifically offer the following recommendations:
Breast Cancer
Starting at age 20, women at all risk levels should practice breast self-awareness by being familiar with how their breasts look and feel and immediately reporting any changes to their doctor. Women aged 40 years and older at average risk should get annual mammograms and breast exams.
For women at increased risk, the type and frequency of exams - including clinical breast exams, mammograms and breast MRI - depend on factors putting them at increased risk, including:
* history of radiation treatment to the chest;
* genetic predisposition;
* diagnosis of lobular carcinoma in situ;
* Gail Model score of greater than 1.7 percent;
* or family history.
Cervical Cancer
For women at average risk, it is now recommended that women under age 21 get a liquid-based Pap test within three years of initiating vaginal intercourse. She should continue to have Pap tests annually until she has had three consecutive negative test results. After that, M. D. Anderson recommends screening every two years unless she is at increased risk of cervical cancer based on risk factors, including:
* history of cervical cancer or severe cervical dysplasia;
* persistently testing positive for Human Papilloma Virus (HPV);
* exposure to diethylstilbestrol (DES) before birth;
* Human Immunodeficiency Virus (HIV) infection;
* or an immune system that does not function properly.
Beginning at age 30, adding HPV testing is a preferred option to the Pap test, and if both are negative, a woman may go to every three years unless she is at increased risk based on the risk factors cited above or unless the optional HPV test was not done.
Colorectal Cancer
M. D. Anderson recommends a colonoscopy every 10 years (preferred screening), a virtual colonoscopy every five years, or a yearly Fecal Occult Blood Test (FOBT) for men and women aged 50 years and older who are at average risk. For men and women at increased or high risk, the type and frequency of exams - including colonoscopy and flexible sigmoidoscopy - depend on the following factors:
* personal history of precancerous (adenomatous) polyps;
* personal history of colorectal cancer;
* family history of colorectal cancer or precancerous (adenomatous) polyps;
* genetic diagnosis of Familial Adenomatous Polyposis;
* genetic history of Hereditary Nonpolyposis Colorectal Cancer or a clinical history suggesting such;
* or inflammatory bowel disease (ulcerative colitis or Crohn's disease).
"Because of the research being conducted in laboratories and clinics at M. D. Anderson and around the world, our understanding of how cancer develops and spreads is steadily increasing," said Ernest T. Hawk, M.D., M.P.H., vice president for Cancer Prevention and Population Sciences.
More knowledge about how doctors make decisions about risk levels and screening tests will give patients a deeper understanding of the disease process and enable them to put their own cancer risk in perspective, he added.
"For colorectal cancer screenings, patients need to be proactive about obtaining results from their screening tests. For example, if a colonoscopy reveals polyps, it is critical for the patient to know what kind, how many and what size, since this information factors heavily into what risk category they fall into for colorectal cancer," Bevers said.
The risk categories and related guidelines were developed by multidisciplinary panels of M. D. Anderson disease site experts across several areas, including: medical oncology, surgical oncology, cancer prevention, imaging and others. Risk-based screening guidelines for prostate, liver, skin, endometrial and ovarian cancers are currently in development and a new online risk assessment tool integrating the new screening guidelines will be launched on the M. D. Anderson Web site in early 2010.
University of Texas M. D. Anderson Cancer Center
Colorectal Cancer Current Events and Colorectal Cancer News RSS'Cross-talk' mechanism contributes to colorectal cancer
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
African-Americans with colorectal cancer have poorer outcomes, lower survival rates
New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans.
Colon cancer screening more effective earlier in day, UCLA study finds
The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed.
1 disease, not 1 demographic
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."
Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients
Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients.
The bowels of infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.
How to Lower Costs, Waiting Times for Colonoscopies
Colorectal cancer is a leading cause of cancer-related deaths in the United States, leading to over 50,000 fatalities every year.
Excess body weight causes over 124,000 new cancers a year in Europe
At least 124,000 new cancers in 2008 in Europe may have been caused by excess body weight, according to estimates from a new modelling study.
Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage.
New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers
Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress.
More Colorectal Cancer Current Events and Colorectal Cancer News Articles
 |
American Cancer Society's Complete Guide to Colorectal Cancer by American Cancer Society (Author) Don't die of embarrassment--get informed about colorectal cancer Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete Guide to Colorectal Cancer provides sound information and support if you are concerned about or diagnosed with colorectal cancer. Written by experts in oncology, nursing, research, and colorectal cancer care, the up-to-date, evidence-based text explores every aspect of colorectal cancer, from physical to emotional aspects of the disease, including: What colorectal... |
 |
Be a Survivor: Colorectal Cancer Treatment Guide by Vladimir Lange (Author) Dr. Lange’s comprehensive overview of cancer and treatment options offers detailed information using simple, concise language and a wide variety of color photos and drawings. Colorectal cancer patients need to know more about their disease, yet there is an overload of information. Be a Survivor gives the patient the specific, reliable and necessary information to make good decisions about their cancer and treatment options. Annually, 150,000 Americans are told they have colorectal cancer, making it one of the top three most common cancers in the United States. Diagnosed early, colorectal cancer is treatable, often curable, and vey preventable. This resource covers all aspects of colorectal cancer—from diagnosis to recovery, including a chapter for the patient's spouse. |
|
Progress in Colorectal Cancer by Mediscript | |
 |
New Tests, Treatments: Better Outcome for Colorectal Cancer Colorectal cancer is the third most common cancer and the second leading cause of cancer mortality in the U.S. Advances in imaging, genetics, molecular diagnostics, surgical techniques and chemotherapy are now making significant gains in our ability to prevent, diagnose, and treat this serious disease. Dr. Fisher reviews some of these recent successes and shares a vision of future care based on current research. |
 |
First Check Home ColoCheck Home Test, Colorectal Disease, 1 Test (Pack of 2) by First Check A First Check at 50 product. No specimen handling. No diet restrictions. FDA cleared. Fast. Accurate. Simple. A home test for the early warning signs of Colorectal Disease. Results in minutes. Early detection is key. First Check ColoCheck provides informa |
|
Screening for Colorectal Cancer: An Easy Step to Save Your Life (Three Real Patient Stories) Also With: American Digestive Health Foundation (Producer), Chuck Peet (Host) | |
 |
Colorectal Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Colorectal Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Colorectal Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Colorectal Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Beating Colorectal Cancer Together Long Sleeve T-shirt Large White by Shop Zeus |
 |
Understanding Colorectal Cancer Anatomical Chart (Laminated) by Anatomical Chart Company Understanding Colorectal Cancer Anatomical Chart defines colorectal cancer and shows colorectal anatomy with the following pathologies: * Adenocarcinoma of colon * Circumferential carcinoma of the transverse colon * Colonic polyps * Adenocarcinoma of jejunum * Adenocarcinoma of the rectosigmoid region The chart describes risk factors, signs and symptoms, screening and diagnostic tests, and treatment options, and illustrates and explains the stages of cancer. |
 |
Beating Colorectal Cancer Together Keychain by Design a Product LLC Text on keychain: Beating Colorectal Cancer Together * Durable acrylic key chain is crystal-clear and double-sided so the artwork or message is seen twice. * Sturdy metal ring holds your keys securely. * Full color printed images or messages are included. * If you have new ideas or need help selecting text for your custom keychains please contact us. * Size: 2 1/8" x 3 1/2" (Approx. business card) |
| © 2009 BrightSurf.com |